It has been found that Nrf2 activation significantly inhibits ferroptosis in melanoma, while Nrf2 inactivation induces ferroptosis thereby sensitizing melanoma to immunotherapy; inhibiting Nrf2-mediated ferroptosis notably improves skin wound healing [45]. The gene discussed is NFE2L2; the disease is melanoma.